| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Panacea Biotec Limited (NSE: PANACEABIO)
PANACEABIO Technical Analysis
2
| As on 25th Jan 2022 PANACEABIO Share Price closed @ 209.55 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 276.14 & Buy for SHORT-TERM with Stoploss of 199.35 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PANACEABIO Share Price
| Open | 207.10 | Change | Price | % |
| High | 211.00 | 1 Day | -0.80 | -0.38 |
| Low | 203.15 | 1 Week | 20.80 | 11.02 |
| Close | 209.55 | 1 Month | 18.35 | 9.60 |
| Volume | 113938 | 1 Year | 12.35 | 6.26 |
| 52 Week High 449.00 | 52 Week Low 165.30 | ||||
NSE INDIA Most Active Stocks
| IDEA | 11.30 | 3.20% |
| VISESHINFO | 1.55 | 3.33% |
| JPPOWER | 9.05 | 2.84% |
| SUZLON | 11.00 | -0.90% |
| ZOMATO | 100.45 | 9.96% |
| YESBANK | 13.60 | 1.12% |
| BANKBARODA | 98.50 | 6.37% |
| PNB | 39.40 | 3.68% |
| ALOKINDS | 29.70 | 2.77% |
| INVENTURE | 5.45 | -4.39% |
NSE INDIA Top Gainers Stocks
| SALONA | 327.00 | 20.00% |
| SHARDACROP | 525.35 | 20.00% |
| AMBICAAGAR | 34.05 | 18.85% |
| PRESSMN | 48.65 | 16.67% |
| CORALFINAC | 49.85 | 14.60% |
| TRITURBINE | 214.30 | 14.42% |
| OMAXE | 93.10 | 13.95% |
| ARMANFIN | 792.95 | 13.76% |
| ORBTEXP | 100.00 | 13.44% |
| BIL | 304.25 | 12.31% |
NSE INDIA Top Losers Stocks
| PANACEABIO Daily Charts |
PANACEABIO Intraday Charts |
Whats New @ Bazaartrend |
PANACEABIO Free Analysis |
|
|
PANACEABIO Important Levels Intraday
| RESISTANCE | 224.68 |
| RESISTANCE | 219.83 |
| RESISTANCE | 216.83 |
| RESISTANCE | 213.83 |
| SUPPORT | 205.27 |
| SUPPORT | 202.27 |
| SUPPORT | 199.27 |
| SUPPORT | 194.42 |
PANACEABIO Target for Month January
| 4th UP TARGET | 298.95 |
| 3rd UP TARGET | 266.78 |
| 2nd UP TARGET | 246.9 |
| 1st UP TARGET | 227.02 |
| 1st DOWN TARGET | 170.28 |
| 2nd DOWN TARGET | 150.4 |
| 3rd DOWN TARGET | 130.52 |
| 4th DOWN TARGET | 98.35 |
PANACEABIO Weekly Target
| 4th UP TARGET | 258.85 |
| 3rd UP TARGET | 243.58 |
| 2nd UP TARGET | 234.15 |
| 1st UP TARGET | 224.71 |
| 1st DOWN TARGET | 197.79 |
| 2nd DOWN TARGET | 188.35 |
| 3rd DOWN TARGET | 178.92 |
| 4th DOWN TARGET | 163.65 |
PANACEABIO Target for Year 2022
| 4th UP TARGET | 745.34 |
| 3rd UP TARGET | 570.01 |
| 2nd UP TARGET | 461.64 |
| 1st UP TARGET | 353.27 |
| 1st DOWN TARGET | 44.03 |
| 2nd DOWN TARGET | -64.34 |
| 3rd DOWN TARGET | -172.71 |
| 4th DOWN TARGET | -348.04 |
Panacea Biotec Limited ( NSE INDIA Symbol : PANACEABIO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PANACEABIO Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is 33.69 | Sideways | |
| MFI (14) | MFI is 44.52 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is -50.73 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 113.24 | |
| 10 Day Avg Volume | Traded 11.97 % More then 10 Day Average Volume | ||
PANACEABIO Other Details
| Segment | EQ | |
| Market Capital | 13730913280.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | > | |
PANACEABIO Address
 |
||
PANACEABIO Latest News
PANACEABIO Business Profile
Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceuticals, vaccines, and biosimilars in India. It operates through Vaccines and Formulations segments. The company's product portfolio includes prescription products in various therapeutic areas, such as pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, and gastro-intestinal care; and vaccines for anthrax, dengue, Japanese encephalitis, and others. It also exports its products to over 30 countries worldwide, including the United States, Germany, the Russian Federation, Sri Lanka, the Philippines etc. The company has a collaboration agreement with Russian Direct Investment Fund for producing Covid-19 vaccine, Sputnik-V. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India. Address: B-1 Extension/G-3, New Delhi, India, 110044
© 2005-2021 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service